Arintra performs autonomous medical coding inside the electronic health record, translating clinical documentation into billing codes and sending them straight to the revenue cycle. Coding is a large, persistent cost in American healthcare: certified coders read physician notes and assign codes under rules that change constantly, and errors surface late as denials, underpayment, or compliance exposure. The work is expensive, the labour pool is tight, and the feedback loop between a miscode and its financial consequence is slow.

The product’s distinguishing choice is to operate autonomously and inside the EHR rather than as a suggestion tool in a separate queue, which is what turns it from a coder productivity aid into a replacement for a manual step. That also raises the accuracy bar, since there is no human reviewing every output. Backed since 2022 and funded through a 21 million dollar Series A, Arintra is an agentic applications investment with an unusually direct return on investment story. Recovered revenue and reduced denial rates are measurable within a quarter, which shortens enterprise sales cycles considerably.